The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kornetova E.G.

Mental Health Research Institute — Tomsk National Research Medical Center, Russian Academy of Science

Galkin S.A.

Mental Health Research Institute of the Tomsk National Research Medical Center of the Russian Academy of Science

Kornetov A.N.

Mental Health Research Centre

Chaika Yu.A.

Mental Health Research Centre

PANSS six-factor model

Authors:

Kornetova E.G., Galkin S.A., Kornetov A.N., Chaika Yu.A.

More about the authors

Read: 2060 times


To cite this article:

Kornetova EG, Galkin SA, Kornetov AN, Chaika YuA. PANSS six-factor model. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(2):28‑34. (In Russ.)
https://doi.org/10.17116/jnevro202512502128

Recommended articles:
Modern concepts of sleep disturbances asso­ciated with mental diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):7-12
Factors supporting chro­nic inflammation in mental illness. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):7-15
Constitutional and morphological bases of suicidal beha­vior in patients with schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(11):52-56
Search for risk factors for slowed intra-atrial conduction in patients with schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(11):111-116

References:

  1. Orsolini L, Pompili S, Volpe U. Schizophrenia: A Narrative Review of Etiopathogenetic, Diagnostic and Treatment Aspects. J Clin Med. 2022;11(17):5040. https://doi.org/10.3390/jcm11175040
  2. Jablensky A. The diagnostic concept of schizophrenia: its history, evolution, and future prospects. Dialogues Clin Neurosci. 2010;12(3):271-287.  https://doi.org/10.31887/DCNS.2010.12.3/ajablensky
  3. Kornetova EG, Galkin SA, Mednova IA, et al. Connections between components of metabolic syndrome and cognitive impairment in patients with schizophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(3):82-87. (In Russ.). https://doi.org/10.17116/jnevro202412403182
  4. Karyakina MV, Rychkova OV, Shmukler AB. Cognitive impairment in schizophrenia in foreign studies: a violation of individual functions or a group of syndromes? Sovremennaya zarubezhnaya psihologiya. 2021;10(2):8-19. (In Russ.). https://doi.org/10.17759/jmfp.2021100201
  5. Kornetov AN, Kornetova EG, Golenkova AV, et al. Neurocognitive deficiency in clinical polymorphism of schizophrenia: typology, severity and syndromic overlap. Byulleten’ sibirskoj mediciny. 2019;18(2):107-118. (In Russ.). https://doi.org/10.20538/1682-0363-2019-2-107-118
  6. Kay SR, Fisbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261-276. 
  7. White L, Harvey PD, Opler L et al. The PANSS Study Group. Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. Psychopathology. 1997;30:263-274. 
  8. Nielsen RE, Lindström E, Telléus GK, et al. Is the PANSS cognitive scale measuring cognition? Nord J Psychiatry. 2014;68(8):573-578.  https://doi.org/10.3109/08039488.2014.898790
  9. Kumar A, Khess CR. Factor analysis of positive and negative syndrome scale in schizophrenia: An exploratory study. Indian J Psychiatry. 2012;54(3):233-238.  https://doi.org/10.4103/0019-5545.102419
  10. Van der Gaag M, Hoffman T, Remijsen M, et al. The five-factor model of the Positive and Negative Syndrome Scale II: a ten-fold cross-validation of a revised model. Schizophr Res. 2006;85(1-3):280-287.  https://doi.org/10.1016/j.schres.2006.03.021
  11. Van der Gaag M, Cuijpers A, Hoffman T, et al. The five-factor model of the Positive and Negative Syndrome Scale I: confirmatory factor analysis fails to confirm 25 published five-factor solutions. Schizophr Res. 2006;85(1-3):273-279.  https://doi.org/10.1016/j.schres.2006.04.001
  12. Bell MD, Lysaker PH, Milstein RM, et al. Concurrent validity of the cognitive component of schizophrenia: relationship of PANSS scores to neuropsychological assessments. Psychiatry Res. 1994;54(1):51-58.  https://doi.org/10.1016/0165-1781(94)90064-7
  13. Bryson G, Bell M, Greig T, et al. Internal consistency, temporal stability and neuropsychological correlates of three cognitive components of the Positive and Negative Syndrome Scale (PANSS). Schizophr Res. 1999;38(1):27-35.  https://doi.org/10.1016/s0920-9964(99)00004-3
  14. González Pablos E, Minués Martín L, Alonso del Teso F, et al. La función cognitiva en la esquizofrenia a través del componente cognitivo de la PANSS. Anales de Psiquiatría. 2005;21:274-279 
  15. Good KP, Rabinowitz J, Whitehorn D, et al. The relationship of neuropsychological test performance with the PANSS in antipsychotic naïve, first-episode psychosis patients. Schizophr Res. 2004;68(1):11-19.  https://doi.org/10.1016/j.schres.2003.07.001
  16. Klingberg S, Wittorf A, Wiedemann G. Disorganization and cognitive impairment in schizophrenia: independent symptom dimensions? Eur Arch Psychiatry Clin Neurosci. 2006;256(8):532-540.  https://doi.org/10.1007/s00406-006-0704-0
  17. Hofer A, Niedermayer B, Kemmler G, et al. Cognitive impairment in schizophrenia: clinical ratings are not a suitable alternative to neuropsychological testing. Schizophr Res. 2007;92(1-3):126-131.  https://doi.org/10.1016/j.schres.2007.01.023
  18. Gil D, Bengochea R, Arrieta M, et al. Validity of the cognitive factor of the Positive and Negative Syndrome Scale as a measure of cognitive functioning in schizophrenia. Rev Psiquiatr Salud Ment. 2009;2(4):160-168.  https://doi.org/10.1016/S1888-9891(09)73234-3
  19. Lançon C, Auquier P, Nayt G, Reine G. Stability of the five-factor structure of the Positive and Negative Syndrome Scale (PANSS). Schizophr Res. 2000;42(3):231-239.  https://doi.org/10.1016/s0920-9964(99)00129-2
  20. Wolthaus JE, Dingemans PM, Schene AH, et al. Component structure of the positive and negative syndrome scale (PANSS) in patients with recent-onset schizophrenia and spectrum disorders. Psychopharmacology (Berl). 2000;150(4):399-403.  https://doi.org/10.1007/s002130000459
  21. Emsley R, Rabinowitz J, Torreman M. The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis. Schizophr Res. 2003;61(1):47-57.  https://doi.org/10.1016/s0920-9964(02)00302-x
  22. Mosolov SN. Scales of psychometric assessment of schizophrenia symptoms and the concept of positive and negative disorders. M. 2001;238. (In Russ.).
  23. Kornetov AN, Yazykov KG, Kornetova EG, et al. Normative assessment of cognitive functions on the scale «brief assessment of cognitive functions in patients with schizophrenia» (BACS) in Tomsk population: constitutional factors of variability. Sibirskij psihologicheskij zhurnal. 2021;(82):137-152. (In Russ.). https://doi.org/10.17223/17267080/82/8
  24. Galkin SA, Kornetova EG, Tiguntsev VV, et al. Spectral parameters of the electroencephalogram in patients with paranoid schizophrenia with varying degrees of neurocognitive deficiency. Rossijskij psihiatricheskij zhurnal. 2023;(4):31-38. (In Russ.). https://doi.org/10.34757/1560-957X.2023.27.4.003
  25. Sarkisyan GR, Gurovich IYa, Kif RS. Normative data for the Russian population and standardization of the scale «brief assessment of cognitive functions in patients with schizophrenia» (BACS). Social’naya i klinicheskaya psihiatriya. 2010;20(3):13-19. (In Russ.).
  26. Tumova MA, Shoshina II, Stanovaya VV, et al. Indicators of cognitive functioning and characteristics of the visual system in schizophrenia: a cross-sectional study. Psihiatriya. 2023;21(3):36-44. (In Russ.). https://doi.org/10.30629/2618-6667-2023-21-3-36-44
  27. Carpenter WT Jr, Buchanan RW. Schizophrenia. N Engl J Med. 1994;330(10):681-690.  https://doi.org/10.1056/NEJM199403103301006
  28. Barkhatova AN, Kaganovich PS, Kolyago OO. On the issue of the conjugacy of depressive and negative disorders in schizophrenia. Social’naya i klinicheskaya psihiatriya. 2021;(3):21-26. (In Russ.).
  29. Mosolov SN. Diagnosis and treatment depression in schizophrenia. Consortium Psychiatricum. 2020;1(2):29-42.  https://doi.org/10.17650/2712-7672-2020-1-2-29-42
  30. Möser C, Krieg JC, Zihl J, et al. Attention and memory deficits in schizophrenia: the role of symptoms of depression. Cogn Behav Neurol. 2006;19(3):150-156. 
  31. Li YT, Zhang C, Han JC, et al. Neuroimaging features of cognitive impairments in schizophrenia and major depressive disorder. Ther Adv Psychopharmacol. 2024;14:20451253241243290. https://doi.org/10.1177/20451253241243290
  32. Halari R, Mehrot ra R, Sharma T, et al. Does self -perceived mood predict more variante in cognit ive performance than clinician-related symptoms in schizophrenia? Schizophr Bull. 2006;32:751-756. 

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.